COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN: CLINICAL PRESENTATION, DIAGNOSIS AND MANAGEMENT
Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality among children worldwide. Despite advances in vaccination and antimicrobial therapy, it remains a significant burden, especially in low- and middle-income countries. This article reviews the epidemiology, clinical features, diagnostic approaches, treatment strategies, and preventive measures for pediatric CAP. Emphasis is placed on ti
Keywords
Pediatrics, community-acquired pneumonia, children, diagnosis, treatment, prevention
References
- World Health Organization. Pneumonia in children: Key facts. WHO, 2022.
- Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines. Clin Infect Dis. 2011;53(7):e25–e76.
- Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381(9875):1405–1416.
- Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845.
- Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics. 2020;146(5):e20200225.
Downloads
Download data is not yet available.